UTI (179900) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, UTI (179900) reported revenue of 20.0 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202520.0 billion KRW-48.3 billion KRW-37.4 billion KRW[source]
202418.6 billion KRW-32.2 billion KRW-22.7 billion KRW[source]
202319.4 billion KRW-19.7 billion KRW-29.6 billion KRW[source]
202236.4 billion KRW-4.6 billion KRW-12.1 billion KRW[source]
202145.2 billion KRW-2.2 billion KRW1.3 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025208.2 billion KRW109.1 billion KRW99.1 billion KRW[source]
2024150.3 billion KRW80.0 billion KRW70.3 billion KRW[source]
202376.4 billion KRW76.3 billion KRW66 million KRW[source]
202290.8 billion KRW61.8 billion KRW29.1 billion KRW[source]
202182.2 billion KRW23.4 billion KRW58.8 billion KRW[source]

Cash Flow

YearOperatingInvestingFinancingSource
2025-35.2 billion KRW-65.3 billion KRW94.8 billion KRW[source]
2024-31.3 billion KRW-11.0 billion KRW85.0 billion KRW[source]
2023-8.4 billion KRW3.3 billion KRW-3.1 billion KRW[source]
20223.2 billion KRW-25.6 billion KRW24.1 billion KRW[source]
20215.8 billion KRW-4.1 billion KRW1.4 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice